AT294774T

Aminoadamantane derivatives as therapeutic agents

Abstract

The invention provides new para-amino amino derivative, wherein the prepared by the method, comprising the novel para-amino amino derivative, and using the derivative and treatment and prevention of diseases method. Use of the invention treatment of a disorder with multiple, comprising as follows: A topical or ischemia the oxygen content in this high composition for a disorder of a wound, having a composition, comprising the middle; the hypoglycemia, a topical ischemia of disease, a second wrestle the limit, huntington's a wound, the perinatal the oxygen content is too low, the compound wrestles the limit and hypoglycemia, dementiaThe of neurodegenerative disorder is amitriptyline, wherein the Alzheimer disease, Metabolic syndrome Parkinson disease neurological the compound, a side involving quenching; Other diseases or disorder to the convulsion, the compound, constrain, wherein the pain, schizophrenia, a reinforcing twitches, comprising a headache, the urine incontinence, wherein the; the meconium peptide preparation of a compound, a disorder of the vomit, the brain, compound of hangfire's disorders, the induction's AIDS dementia, the water-cooling injury, retinopathy, knew, and infects of the composition and a HIV, the upper, function is balance of sports and organ defined.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

28 members in 14 offices

This recordMember, by publication datePriority claim4 more offices are in the list below

Priority claims2

Priority claims
DocumentOfficeKindDate
51009900United States of AmericaA
0105967United States of AmericaW

Members28

Family members, oldest first
DocumentOfficeKind
CA2400916A1CanadaA1
WO0162706A1World Intellectual Property Organization (WIPO)A1
AU4327101AAustraliaA
US6444702B1United States of AmericaB1
EP1259477A1European Patent Office (EPO)A1
US2003008889A1United States of AmericaA1
BR0108547ABrazilA
JP2003523989AJapanA
US6620845B2United States of AmericaB2
CN1446193AChinaA
HK1052921A1Hong Kong, ChinaA1
US2004029929A1United States of AmericaA1
AU2001243271B2AustraliaB2
EP1259477B1European Patent Office (EPO)B1
AT294774TThis recordAustriaT
ATE294774T1AustriaT1
DE60110557D1GermanyD1
MXPA02008170AMexicoA
EP1568685A1European Patent Office (EPO)A1
PT1259477EPortugalE
ES2243468T3SpainT3
DE60110557T2GermanyT2
US2006106222A1United States of AmericaA1
CN100339356CChinaC
US7326730B2United States of AmericaB2
US2008183003A1United States of AmericaA1
JP4317343B2JapanB2
CA2400916CCanadaC